AAMU
AXDX

Amundi Asset Management US’s Accelerate Diagnostics AXDX Stock Holding History

Amundi Asset Management US’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-9,310
Closed -$2.13M – 1629
2019
Q2 		$2.13M Sell
9,310
-43,795
-82% -$8.56M ﹤0.01% 1128
2019
Q1 		$11.2M Sell
53,105
-46,004
-46% -$8.63M 0.02% 688
2018
Q4 		$11.4M Buy
99,109
+24,600
+33% +$3.64M 0.01% 620
2018
Q3 		$17.1M Buy
74,509
+21,065
+39% +$4.66M 0.02% 585
2018
Q2 		$11.9M Buy
53,444
+14,455
+37% +$3.23M 0.02% 677
2018
Q1 		$8.91M Buy
38,989
+18,720
+92% +$4.92M 0.01% 707
2017
Q4 		$5.31M Buy
+20,269
New +$4.75M 0.01% 826

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Amundi Asset Management US's AXDX Position: Q3 2019 in Review

Amundi Asset Management US sold out of Accelerate Diagnostics (AXDX) in Q3 2019, closing a stake of 9,310 shares — an estimated $2.13M sold.

Amundi Asset Management US first reported a position in AXDX in Q4 2017 and held it in 7 quarters. The position peaked at $17.1M in Q3 2018. 113 funds tracked by Wall St. Rank hold AXDX as of Q3 2019.

  • Amundi Asset Management US reported no remaining Accelerate Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 9,310 Accelerate Diagnostics shares in Q3 2019, an estimated $2.13M.
  • Amundi Asset Management US first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 7 quarters.
  • Amundi Asset Management US's Accelerate Diagnostics position peaked at $17.1M in Q3 2018.
  • 113 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2019.

Based on Amundi Asset Management US's 13F filing for Q3 2019, filed 14 Nov 2019.